Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis have?
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis has 195 citations in the OpenAlex counts ScholarIQ stores.
When was Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis published?
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis has 2017 year in the ScholarIQ index.
What is the open-access status of Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis?
Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis has gold oa status in the ScholarIQ index.
What is the DOI of Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis?
The DOI for Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis is on the source record.
What is the PMID of Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis?
The PMID for Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis is on the source record.
What is the OpenAlex record for Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis?
The OpenAlex for Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis is on the source record.